Related Experiment Video
Updated: Nov 24, 2025
A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Solitary Cardiac Metastasis of Hepatocellular Carcinoma
Hideki Aoki1, Masashi Utsumi1, Yuji Kimura1
1Department of Surgery, National Hospital Organization Iwakuni Clinical Center.
Insights
Cardiac metastasis from hepatocellular carcinoma (HCC) is rare. This case study shows that combining radiotherapy and chemotherapy may effectively treat cardiac tumors in HCC patients, improving survival.
Area of Science:
- Oncology
- Cardiology
- Hepatology
Background:
- Hepatocellular carcinoma (HCC) rarely metastasizes to the heart.
- Established therapeutic standards for cardiac metastasis from HCC are lacking.
- Cardiac metastasis from HCC carries a poor prognosis.
Observation:
- A 64-year-old male with a history of hepatitis B virus-positive HCC presented with isolated cardiac metastasis.
- The tumor was located in the right ventricle, 19 months post-hepatectomy.
- The patient received a combination of radiotherapy and chemotherapy.
Findings:
- The patient survived over 3 years after the diagnosis of cardiac metastasis.
- The combined treatment regimen demonstrated efficacy in managing the cardiac tumor.
Implications:
- Radiotherapy combined with chemotherapy offers a potential treatment strategy for cardiac metastasis of HCC.
- This approach may improve survival outcomes for patients with this rare condition.
- Further research is warranted to establish definitive treatment guidelines.
Abstract:
Cardiac metastasis originating from hepatocellular carcinoma (HCC) is a rare condition with a poor prognosis. No therapeutic standards for cardiac metastasis originating from HCC have been established. At 19 months after a curative hepatectomy, a 64-year-old Japanese hepatitis B virus-positive male patient experienced solitary cardiac metastasis originating from HCC. The cardiac tumor was discovered in the right ventricle. The patient received three courses of radiotherapy and chemotherapy and survived > 3 years after the initial diagnosis of cardiac metastasis. His case demonstrates that radiotherapy combined with chemotherapy can be an effective treatment for cardiac metastasis.
